Virax Biolabs Group Ltd. Class A
(NASDAQ: VRAX)

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

0.644

-0.044 (-6.40%)
Range 0.560 - 0.650   (16.07%)
Open 0.620
Previous Close 0.688
Bid Price 0.430
Bid Volume 14
Ask Price 0.435
Ask Volume 30
Volume 5,814,762
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events


Top Contributors

JonWick38 avatar
11359
Followers 272
Posts 2459

Loading Chart...

Please login to view stock data and analysis